Researchers typically study CJC-1295 with DAC for its effect on the GH/IGF-1 axis and for sustained stimulation of endogenous growth-hormone release. In FAQ copy, the useful distinction is that it is designed for longer activity than non-DAC versions, which affects how researchers think about pulse pattern and study timing.
Frequently Asked Questions
Explore answers to our most commonly asked questions about CBD, our products, and more.
CJC-1295 with DAC is a long-acting analog of growth hormone-releasing hormone. The DAC portion refers to a drug-affinity complex added to prolong circulation time, which is why it is usually distinguished from shorter-acting GHRH analogs. It should be presented as a research peptide for endocrine signaling studies only.